A new approach to choosing hormonal contraception through systematization of existing drugs
- Authors: Tikhomirov A.L.1, Manukhin I.B.1, Gevorkyan M.A.1, Manukhina E.I.1, Kazenashev V.V.1
-
Affiliations:
- A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia
- Issue: No 2 (2017)
- Pages: 113-118
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/247925
- DOI: https://doi.org/10.18565/aig.2017.2.113-8
- ID: 247925
Cite item
Abstract
Keywords
Full Text
About the authors
Aleksandr L. Tikhomirov
A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia
Email: tikhomiroval@yandex.ru
MD, PhD, Professor of Faculty of Medicine Obstetrics and Gynecology Department
Igor B. Manukhin
A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of RussiaMD, PhD, Professor, Head of Faculty of Medicine Obstetrics and Gynecology Department
Mariyana A. Gevorkyan
A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia
Email: marianagevorkyan@mail.ru
MD, PhD, Professor of Faculty of Medicine Obstetrics and Gynecology Department
Ekaterina I. Manukhina
A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia
Email: katemanu@mail.ru
MD, PhD, Professor of Faculty of Medicine Obstetrics and Gynecology Department
Viktor V. Kazenashev
A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia
Email: vkazenashev@mail.ru
MD, PhD, Assistant of Faculty of Medicine Obstetrics and Gynecology Department
References
- World Contraceptive Use 2003. United Nations Department of Economic and Social Affairs Population Division.
- Статистическая информация Минздрава России. Available at: https:// www.rosminzdrav.ru/ministry/61/22/stranitsa-979/statisticheskaya-informatsi-ya-minzdrava-rossii [Statistical information of Ministry of Health of Russia. Available at: https://www.rosminzdrav.ru/ministry/61/22/stranitsa-979/statis-ticheskaya-informatsiya-minzdrava-rossii (in Russian)]
- Прилепская В.Н., ред. Руководство по контрацепции. М.: МЕДпресс-информ; 2010. 448с. [Prilepskaya V.N., ed. Contraceptive Guide. Moscow: MEDpress-inform; 2010. 448p. (in Russian)]
- Armstrong C. ACOG Guidelines on noncontraceptive uses of hormonal contraceptives. Am. Fam. Physician. 2010; 82(3): 288-95.
- Wiegratz I., Kuhl H. Metabolic and clinical effects of progestogens. Eur. J. Contracept. Reprod. Health Care. 2006; 11(3): 153-61.
- Blanc A.K., Curtis S., Croft T. Does contraceptive discontinuation matter? Quality of care and fertility consequences. MEASURE Evaluation Technical Report Series No. 3. Carolina Population Center, University of North Carolina at Chapel Hill; 1999.
- Volumetric concept test. Ipsos, 2014.
- Usage & Attitude, GFK, 2012.
- Akerlund M., Rede A., Westergaard J. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol. Br. J. Obstet. Gynaecol. 1993; 100(9): 832-8.
- Endrikat J.S., Milchev N.P., Kapamadzija A., Georgievska J., Gerlinger C., Schmidt W., Feroze S. Bleeding pattern, tolerance and patient satisfaction with a drospirenone-containing oral contraceptive evaluated in 3488 women in Europe, the Middle East and Canada. Contraception. 2009; 79(6): 428-32.
- Дубровина С.О. Синдром поликистозных яичников: современный обзор. Гинекология. 2016; 18(5): 14-9. [Dubrovina S.O. Polycystic ovary syndrome: modern review. Ginekologiya. 2016; 18(5): 14-9. (in Russian)]
- Ткаченко Л.В., Свиридова Н.И. Гиперпластические процессы эндометрия в пременопаузе: современные возможности гормональной коррекции и профилактики. Гинекология. 2013; 15(2): 8-12. [Tkachenko L.V., Sviridova N.I. Endometrial hyperplasia in premenopausal women: modern possibilities of hormonal correction and prevention. Ginekologiya. 2013; 15(2): 8-12. (in Russian)]
- Sitruk-Ware R. Pharmacological profile of progestins. Maturitas. 2008; 61(1-2): 151-7.
- Lopez L.M., Kaptein A.A., Helmerhorst F.M. Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database Syst. Rev. 2012; (2): CD006586.
- Lucky A.W., Koltun W., Thiboutot D., Niknian M., Sampson-Landers C., Korner P., Marr J. A combined oral contraceptive containing 3-mg drospirenone/ 20-microg ethinyl estradiol in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled study evaluating lesion counts and participant self-assessment. Cutis. 2008; 82(2): 143-50.
- Niemeier V., Kupfer J., Gieler U. Acne vulgaris--psychosomatic aspects. J. Dtsch. Dermatol. Ges. 2006; 4(12): 1027-36.
- Jones-Caballero M., Chren M.M., Soler B., Pedrosa E., Peñas P.F. Quality of life in mild to moderate acne: relationship to clinical severity and factors influencing change with treatment. J. Eur. Acad. Dermatol. Venereol. 2007; 21(2): 219-26.
- Aydinlik S., Kaufmann J., Lachnit-Fixson U., Lehnert J. Long-term therapy of signs of androgenisation with a low-dosed antiandrogen-oestrogen combination. Clin. Trials J. 1990; 27(6): 392-402.
- Национальные медицинские критерии приемлемости методов контрацепции. М.; 2012. [National medical eligibility criteria of contraceptive methods. Moscow; 2012. (in Russian)]
- WHO. Medical eligibility criteria for contraceptive use. 5th ed. 2015. 267p.
- Здравоохранение в России 2015. Статистический сборник/Росстат. М.; 2015. 174с.
- Korver T. et al. A double-blind study comparing the contraceptive efficacy, acceptability and safety of two progestogen-only pills containing desogestrel 75 micrograms/day or levonorgestrel 30 micrograms/day. Collaborative Study Group on the Desogestrel-containing Progestogen-only Pill. Eur. J. Contracept. Reprod. Health Care. 1998; 3(4): 169-78.